The management of blood safety in the presence of uncertain risk: a United kingdom perspective.

Abstract:

:Millions of patients in the UK benefit from the use of both plasma derivatives and blood components that are seen as critical interventions in current medicine. Measures are in place to significantly reduce the risks associated with blood transfusion and plasma derivatives; however, these measures themselves are not risk free. Over the past 20 years, advances in technology and regulation have seen major reductions in the risks associated with transfusion. International blood services, industry, and regulators strive to maintain safety levels through constant monitoring, assessment, and response to changing risk factors. Regulation of screening tests together with the development and introduction of nucleic acid technique tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus has improved blood safety. However, other risks, including the changing epidemiology of transfusion-transmitted infections, bacterial contamination of platelets, incorrect blood component transfusion, and variant Creutzfeldt-Jakob disease, require further attention. Risks such as these are often complex, and there is a difficult balance to be struck between donors/recipients' benefit and adequacy of blood supply. The introduction of any new safety measure therefore requires robust, evidence-based evaluation of associated benefit, both clinical and economical. This review presents a UK perspective on how the safety of the blood supply is maintained in the face of uncertain risks.

journal_name

Transfus Med Rev

authors

Watkins NA,Dobra S,Bennett P,Cairns J,Turner ML

doi

10.1016/j.tmrv.2011.09.003

subject

Has Abstract

pub_date

2012-07-01 00:00:00

pages

238-51

issue

3

eissn

0887-7963

issn

1532-9496

pii

S0887-7963(11)00091-5

journal_volume

26

pub_type

杂志文章,评审
  • Red Blood Cell Alloimmunization in Transfused Patients With Sickle Cell Disease in Sub-Saharan Africa; a Systematic Review and Meta-Analysis.

    abstract::Sickle cell disease (SCD) is the most common monogenic disorder in sub-Saharan Africa (SSA). Blood transfusion to increase the oxygen carrying capacity of blood is vital in the management of many patients with SCD. However, red blood cell (RBC) alloimmunization is a major challenge to transfusions in these patients. C...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.tmrv.2019.06.003

    authors: Boateng LA,Ngoma AM,Bates I,Schonewille H

    更新日期:2019-07-01 00:00:00

  • Clinical trial opportunities in Transfusion Medicine: proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium.

    abstract::The use of blood products to support patients undergoing the large variety of medical and surgical interventions requiring such support has continued to escalate very significantly over time. Relevantly, significant practice variation in the use of blood products exists among practitioners and institutions, largely be...

    journal_title:Transfusion medicine reviews

    pub_type:

    doi:10.1016/j.tmrv.2010.05.002

    authors: Blajchman MA,Glynn SA,Josephson CD,Kleinman SH,State-of-the Science Symposium Transfusion Medicine Committee.

    更新日期:2010-10-01 00:00:00

  • Electronic crossmatching.

    abstract::The crossmatch (XM) is an important part of routine pretransfusion testing. It is used to detect ABO incompatibility and other clinically significant antibodies. The XM has been modified many times and, in recent years, has been abbreviated. The 2 common types of XM currently being done are the immediate spin XM for a...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2005.08.007

    authors: Arslan O

    更新日期:2006-01-01 00:00:00

  • Putting the pieces together: Roger I. Lee and modern transfusion medicine.

    abstract::Roger Irving Lee (1881-1964) played significant scientific and leadership roles in overcoming the clinical impediments to blood transfusion in the 1910s. He developed the first successful anticoagulant system, paraffinized glass, and the first sterile system for indirect transfusion without defibrination, the Lee-Vinc...

    journal_title:Transfusion medicine reviews

    pub_type: 传,历史文章,杂志文章

    doi:10.1016/j.tmrv.2004.09.003

    authors: Stansbury LG,Hess JR

    更新日期:2005-01-01 00:00:00

  • The structure and function of the molecules that carry human red blood cell and platelet antigens.

    abstract::A number of molecules on the surface of red blood cells (RBCs) and platelets express antigenic activity. Various biochemical and molecular approaches have been used to determine the structure and possible function that these molecules have for their respective cell types. The existence of variant molecules and null ph...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2004.03.006

    authors: Denomme GA

    更新日期:2004-07-01 00:00:00

  • Neonatal Platelet Transfusions and Future Areas of Research.

    abstract::Thrombocytopenia affects approximately one fourth of neonates admitted to neonatal intensive care units, and prophylactic platelet transfusions are commonly administered to reduce bleeding risk. However, there are few evidence-based guidelines to inform clinicians' decision-making process. Developmental differences in...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2016.05.009

    authors: Sola-Visner M,Bercovitz RS

    更新日期:2016-10-01 00:00:00

  • The Role of Complement in Hereditary Angioedema.

    abstract::Low levels of C1 inhibitor, the main inhibitor of the classic complement system, result in paroxysmal angioedema attacks that can be incapacitating or even life-threatening in affected individuals. Molecular defects in the gene for C1 inhibitor cause hereditary angioedema. In recent years, new insights in the pathways...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2019.08.002

    authors: Levi M,Cohn DM

    更新日期:2019-10-01 00:00:00

  • The regulation of complement on cell surfaces.

    abstract::The regulation of complement at the surface of cells is mediated by both plasma and membrane proteins. These molecules act in concert to prevent the accelerated catabolism of complement proteins and the concomitant lysis of homologous blood cells. The deficiency of either a plasma or membrane protein predisposes to th...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0887-7963(91)70199-5

    authors: Devine DV

    更新日期:1991-04-01 00:00:00

  • Increasing patient safety and efficiency in transfusion therapy using formal process definitions.

    abstract::The administration of blood products is a common, resource-intensive, and potentially problem-prone area that may place patients at elevated risk in the clinical setting. Much of the emphasis in transfusion safety has been targeted toward quality control measures in laboratory settings where blood products are prepare...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2006.08.007

    authors: Henneman EA,Avrunin GS,Clarke LA,Osterweil LJ,Andrzejewski C Jr,Merrigan K,Cobleigh R,Frederick K,Katz-Bassett E,Henneman PL

    更新日期:2007-01-01 00:00:00

  • Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.

    abstract::Although the risk of infection by blood transfusion is relatively low, breakthrough infections still occur, Transfusion-related fatalities caused by infections continue to be reported, and blood is not tested for many potentially dangerous pathogens. The current paradigm for increasing the safety of the blood supply i...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2004.11.005

    authors: Allain JP,Bianco C,Blajchman MA,Brecher ME,Busch M,Leiby D,Lin L,Stramer S

    更新日期:2005-04-01 00:00:00

  • Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion?

    abstract::There is difficulty in obtaining adequate supplies of blood components, as well as disappointing performance of stabilized or recombinant hemoglobins, limited indications of oxygen transporters (perfluorocarbons), and slow development of "universal" red blood cells (RBCs). There is, therefore, a need for complementary...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2006.11.004

    authors: Douay L,Andreu G

    更新日期:2007-04-01 00:00:00

  • Pathogen reduction: a precautionary principle paradigm.

    abstract::Although remarkable advances have been made in the prevention of the major transfusion-transmitted diseases, long intervals have transpired between the first recognition of transfusion risk and the implementation of a preventive strategy. For hepatitis B virus, that interval was 30 years; for non-A, non-B/hepatitis C ...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章

    doi:10.1016/j.tmrv.2008.01.001

    authors: Alter HJ

    更新日期:2008-04-01 00:00:00

  • Use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review.

    abstract::The use of prothrombin complex concentrates (PCCs) and fibrinogen concentrates (FIBCs) to achieve hemostasis in the perioperative setting as alternatives to allogeneic blood products remains controversial. To examine the efficacy and safety of PCCs and FIBCs, we conducted a systematic review-in accordance with the Pre...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2013.01.002

    authors: Lin DM,Murphy LS,Tran MH

    更新日期:2013-04-01 00:00:00

  • Complement and Coagulation: Cross Talk Through Time.

    abstract::Two complex protein defense systems-complement and coagulation-are based on amplifying enzyme cascades triggered by specific local stimuli. Excess systemic activation of either system is pathologic and is normally prevented by a family of regulatory proteins. The 2 systems are ancient biological processes which share ...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2019.08.004

    authors: Dzik S

    更新日期:2019-10-01 00:00:00

  • Is human herpesvirus-8 transmitted by transfusion?

    abstract::Studies of human herpesvirus-8 (HHV-8) transmission through transfusion have produced contradictory results. In North America-a region with a low prevalence of HHV-8 infection-3 studies that tested specimens from linked positive-donor/negative-recipient pairs collected before the introduction of white blood cell (WBC)...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2009.09.001

    authors: Vamvakas EC

    更新日期:2010-01-01 00:00:00

  • Uses and sources of data on long-term survival after blood transfusion.

    abstract::Several public policy decisions in transfusion medicine require information on the long-term (> or =10-year) survival of transfused patients. This information is needed (1) to estimate the number of surviving transfusion recipients who have contracted a particular infection through transfusion, (2) to assess the cost-...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0887-7963(03)00019-1

    authors: Vamvakas EC

    更新日期:2003-07-01 00:00:00

  • The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline.

    abstract::This guideline for the use of immunoglobulin (IG) for sensitized patients undergoing solid organ transplantation (SOT) is an initiative of the Canadian Blood Services and the National Advisory Committee on Blood and Blood Products of Canada to (1) provide guidance for Canadian practitioners involved in the care of pat...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2009.09.010

    authors: Shehata N,Palda VA,Meyer RM,Blydt-Hansen TD,Campbell P,Cardella C,Martin S,Nickerson P,Peltekian K,Ross H,Waddell TK,West L,Anderson D,Freedman J,Hume H

    更新日期:2010-01-01 00:00:00

  • Cost-effectiveness analysis: what it really means for transfusion medicine decision making.

    abstract::Some have suggested that "blood is different," and the role for cost-effectiveness is thus circumscribed. In this article, the authors start by reviewing key concepts in health economics and economic analysis methods. Examples are drawn from published blood safety studies. After explaining the underlying reasoning beh...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2008.09.001

    authors: Custer B,Hoch JS

    更新日期:2009-01-01 00:00:00

  • In vitro assessment of platelet function.

    abstract::With the realization that the skin bleeding time is often an unreliable measure of platelet function, efforts have been made to identify ways to assess qualitative platelet dysfunction. Currently available techniques measure platelet adhesion, platelet aggregation, the ability of platelets to retard or stop flow throu...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1053/tm.1997.0110106

    authors: Carr ME Jr

    更新日期:1997-04-01 00:00:00

  • Virus inactivation in blood components by photoactive phenothiazine dyes.

    abstract::The virucidal properties of photoactive phenothiazine dyes, such as methylene blue, have been known approximately 70 years. The mechanism of virus inactivation involves binding of the dye to nucleic acid, absorption of light, generation of reactive oxygen species, guanine oxidation in the viral genome. The first pract...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1053/tmrv.2002.29405

    authors: Wagner SJ

    更新日期:2002-01-01 00:00:00

  • Centralized transfusion service: a novel approach to the delivery of transfusion services.

    abstract::The development and expansion of the CTS in Pittsburgh shows the feasibility of this transfusion medicine delivery system. Few of the changes driven by health care reform both improve patient care and reduce costs. When properly implemented, a CTS achieves these objectives, benefits the community as a whole, and enhan...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0887-7963(05)80051-3

    authors: Triulzi DJ,Portman WH,Mango PD,Lopez-Plaza I,Hahn LF

    更新日期:1995-04-01 00:00:00

  • Does hybridoma technology still have a place in transfusion medicine?

    abstract::Hybridoma technology has contributed to virtually all areas of biology and medicine and set the scene for important advances in cell biology and immunodiagnostics. Blood transfusion and transfusion medicine have benefited significantly from development in hybridoma technology, and this has resulted in the generation o...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1053/tmrv.2002.33436

    authors: Yuan FF,Watt JM,Geczy AF

    更新日期:2002-07-01 00:00:00

  • Passenger Lymphocyte Syndrome; a Review of the Diagnosis, Treatment, and Proposed Detection Protocol.

    abstract::Passenger lymphocyte syndrome (PLS) is caused by the transfer of B-lymphocytes present in the donor graft into the recipient circulation following solid organ or hematopoietic stem cell transplantation. These cells may produce antibodies against the recipient's red blood cells, thereby triggering antibody dependent cy...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2020.06.004

    authors: Moosavi MM,Duncan A,Stowell SR,Roback JD,Sullivan HC

    更新日期:2020-07-01 00:00:00

  • Evidence-Based Red Blood Cell Transfusion Practices in Cardiac Surgery.

    abstract::Cardiac surgical patients are among the highest consumers of allogeneic red blood cells (RBCs) due to the prevalence of anemia and bleeding. Up until recently, there was a paucity of high-quality evidence informing transfusion decisions in this patient group which led to wide variability in transfusion decision making...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2017.06.001

    authors: Patel NN,Murphy GJ

    更新日期:2017-10-01 00:00:00

  • The Canadian blood donor health assessment questionnaire: lessons from history, application of cognitive science principles, and recommendations for change.

    abstract::Over the last 20 years, the Canadian Blood Services' (CBS) Donor Health Assessment Questionnaire (DHAQ), used to screen prospective blood donors to determine their eligibility, has grown in complexity and length. Its growth is inextricably linked to the evolution of the environment within which CBS operates from unreg...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2007.03.002

    authors: O'Brien SF,Ram SS,Vamvakas EC,Goldman M

    更新日期:2007-07-01 00:00:00

  • Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.

    abstract::Despite significant advancements in the production of platelet products, storage, and transfusion, transfusion refractoriness remains a significant clinical problem, affecting up to 14% of hematological patients receiving platelet transfusions. Human leukocyte antigen (HLA) alloimmunization is a major cause of immune ...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2020.09.010

    authors: Saris A,Pavenski K

    更新日期:2020-10-01 00:00:00

  • Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes.

    abstract::An international multidisciplinary panel of 15 experts reviewed 494 published articles and used the RAND/UCLA Appropriateness Method to determine the appropriateness of allogeneic red blood cell (RBC) transfusion based on its expected impact on outcomes of stable nonbleeding patients in 450 typical inpatient medical, ...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,多中心研究,评审

    doi:10.1016/j.tmrv.2011.02.001

    authors: Shander A,Fink A,Javidroozi M,Erhard J,Farmer SL,Corwin H,Goodnough LT,Hofmann A,Isbister J,Ozawa S,Spahn DR,International Consensus Conference on Transfusion Outcomes Group.

    更新日期:2011-07-01 00:00:00

  • James Blundell, Obstetrical Hemorrhage, and the Origins of Transfusion Medicine.

    abstract::Although James Blundell is rightly acknowledged as the father of modern transfusion therapy, a review of the events surrounding the initial human-to-human transfusions in the first decades of the 19th century reveals substantial contributions by Blundell's collaborators. Bundell's uncle John Haighton provided substant...

    journal_title:Transfusion medicine reviews

    pub_type: 传,历史文章,杂志文章,评审

    doi:10.1016/j.tmrv.2018.08.003

    authors: Dzik S

    更新日期:2018-10-01 00:00:00

  • Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies.

    abstract::Significant progress has been made in reducing the risk of pathogen transmission to transfusion recipients. Nonetheless, there remains a continuing risk of transmission of viruses, bacteria, protozoa, and prions to recipients. These include many of the viruses for which specific screening tests exist as well as pathog...

    journal_title:Transfusion medicine reviews

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1016/j.tmrv.2007.09.001

    authors: Webert KE,Cserti CM,Hannon J,Lin Y,Pavenski K,Pendergrast JM,Blajchman MA

    更新日期:2008-01-01 00:00:00

  • What a difference 2 nucleotides make: a short review of ABO genetics.

    abstract::ABO is the most important blood group system for transfusion and solid organ transplantation, but it is only over the past 15 years that the techniques for studying its molecular basis became mainstream. Many of its common and rare alleles are now well characterized and by using various expression systems, their effec...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2005.02.003

    authors: Yazer MH

    更新日期:2005-07-01 00:00:00